Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 248

Similar articles for PubMed (Select 20005508)

1.

Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids.

Shammas MC, Lai EC, Sarkar JS, Yang J, Starr CE, Sippel KC.

Am J Ophthalmol. 2010 Feb;149(2):203-213.e2. doi: 10.1016/j.ajo.2009.08.040. Epub 2009 Dec 14.

PMID:
20005508
2.

Stevens-Johnson syndrome and toxic epidermal necrolysis: The Food and Drug Administration adverse event reporting system, 2004-2013.

Abe J, Mataki K, Umetsu R, Ueda N, Kato Y, Nakayama Y, Kinosada Y, Hara H, Inagaki N, Nakamura M.

Allergol Int. 2015 Jul;64(3):277-9. doi: 10.1016/j.alit.2015.01.002. Epub 2015 Feb 7. No abstract available.

3.

Stevens-Johnson syndrome: Old and new opportunities for prevention.

Di Marco N, Schaink JM, Cranswick NE, Sawyer SM.

J Paediatr Child Health. 2015 May 4. doi: 10.1111/jpc.12883. [Epub ahead of print] No abstract available.

PMID:
25940502
4.

Ocular manifestation, complications and aetiological factors in Stevens-Johnson syndrome/toxic epidermal necrolysis.

Chhipa SA, Masood S, Salarzai Y, Khan QA, Ahmad K, Sajid S.

J Pak Med Assoc. 2015 Jan;65(1):62-4.

PMID:
25831677
5.

Extracutaneous manifestations and long-term sequelae of Stevens-Johnson syndrome/toxic epidermal necrolysis.

Vercueil A, Walsh S.

Br J Dermatol. 2015 Feb;172(2):312. doi: 10.1111/bjd.13631. No abstract available.

PMID:
25660673
6.

Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional analysis of patients in an integrated allergy repository of a large health care system.

Blumenthal KG, Wickner PG, Lau JJ, Zhou L.

J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):277-280.e1. doi: 10.1016/j.jaip.2014.10.002. Epub 2014 Nov 18. No abstract available.

PMID:
25609329
7.

Mixed signals: toxic epidermal necrolysis.

Villano JH, Lovell EO.

Am J Med. 2015 Mar;128(3):254-6. doi: 10.1016/j.amjmed.2014.11.004. Epub 2014 Nov 18. No abstract available.

PMID:
25460525
8.

Recurrent blisters in a case of resolving Stevens-Johnson syndrome/toxic epidermal necrolysis.

Chuang YN, Ho YY, Chiu TM.

Indian J Dermatol Venereol Leprol. 2014 Nov-Dec;80(6):546-7. doi: 10.4103/0378-6323.144187. No abstract available.

9.

Recurrence of Stevens-Johnson syndrome and toxic epidermal necrolysis--reply.

Finkelstein Y, Macdonald EM, Juurlink DN.

JAMA. 2014 Oct 15;312(15):1591. doi: 10.1001/jama.2014.10783. No abstract available.

PMID:
25321919
10.

Recurrence of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Stern RS.

JAMA. 2014 Oct 15;312(15):1590-1. doi: 10.1001/jama.2014.10777. No abstract available.

PMID:
25321917
11.

Re: Toxic epidermal necrolysis (TEN): The Chelsea and Westminster hospital wound management algorithm.

Lindford A, Vuola J.

J Plast Reconstr Aesthet Surg. 2015 Feb;68(2):288-9. doi: 10.1016/j.bjps.2014.09.031. Epub 2014 Sep 23. No abstract available.

PMID:
25282634
12.

Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis.

Papakostas TD, Le HG, Chodosh J, Jacobs DS.

Ophthalmology. 2015 Feb;122(2):248-53. doi: 10.1016/j.ophtha.2014.08.015. Epub 2014 Oct 1.

PMID:
25282251
13.

The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.

Kim DH, Yoon KC, Seo KY, Lee HS, Yoon SC, Sotozono C, Ueta M, Kim MK.

Ophthalmology. 2015 Feb;122(2):254-64. doi: 10.1016/j.ophtha.2014.08.013. Epub 2014 Sep 26.

PMID:
25262319
14.

Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis.

White JC, Appleman S.

Pediatrics. 2014 Oct;134(4):e1194-8. doi: 10.1542/peds.2013-2239. Epub 2014 Sep 22. Review.

PMID:
25246624
15.
16.

Ibuprofen-induced extensive toxic epidermal necrolysis - a multidisciplinary therapeutic approach in a single case.

Balint B, Stepic N, Todorovic M, Zolotarevski L, Ostojic G, Vucetic D, Pavlovic M, Novakovic M.

Blood Transfus. 2014 Jul;12(3):438-9. doi: 10.2450/2014.0065-14. No abstract available.

17.

Toxic epidermal necrolysis reaction associated with the use of moxifloxacin.

Howard-Thompson A, Cartmell B, Suda KJ.

Int J Antimicrob Agents. 2014 Aug;44(2):178-9. doi: 10.1016/j.ijantimicag.2014.04.002. Epub 2014 May 2. No abstract available.

PMID:
25052867
18.

Toxic epidermal necrolysis and early transfer to a regional burn unit: is it time to reevaluate what we teach?

Kaffenberger BH, Rosenbach M.

J Am Acad Dermatol. 2014 Jul;71(1):195-6. doi: 10.1016/j.jaad.2013.12.048. No abstract available.

PMID:
24947692
19.

Otologic complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Hotaling JM, Hotaling AJ.

Int J Pediatr Otorhinolaryngol. 2014 Aug;78(8):1408-9. doi: 10.1016/j.ijporl.2014.03.037. Epub 2014 May 2.

PMID:
24933358
20.

Recurrence and mortality following severe cutaneous adverse reactions.

Finkelstein Y, Macdonald EM, Li P, Hutson JR, Juurlink DN.

JAMA. 2014 Jun 4;311(21):2231-2. doi: 10.1001/jama.2014.839. No abstract available.

PMID:
24893093
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk